Galmed Pharmaceuticals

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$0
$0
$0
$0
EBITDA
-2,109
-1,264
-2,011
EBIT
-3,209
Net Income
-2,495
-1,104
-3,209
-1,914
Net Change In Cash
0
0
0
0
Free Cash Flow
-1,268
-1,167
-1,969
-1,064
Cash
4,964
4,767
4,652
9,724
Basic Shares
3,948
1,779
1,664
69

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-83
-31
-35
-42
EBITDA
-7,419
-6,870
-17,616
-32,839
EBIT
-7,502
-6,901
-17,651
-32,881
Net Income
-7,517
-6,912
-18,571
-31,948
Net Change In Cash
0
0
0
0
Free Cash Flow
-5,880
-6,137
-18,505
-32,903
Cash
4,652
2,861
2,016
2,884
Basic Shares
930
230
1,676
1,639

Earnings Calls

Quarter EPS
2025-09-30
$0
2025-06-30
-$0.63
2025-03-31
-$0.62
2024-12-31
-$1.94